Investors are still excited about obesity treatments and weight-management drugs.
It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.
Stocks that traded heavily or had substantial price changes on Monday: Boeing, Alaska Air Group fall; Harpoon Therapeutics, Axonics rise
December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...
Jazz (JAZZ) delivered earnings and revenue surprises of -7.28% and 0.59%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Chinook (KDNY) delivered earnings and revenue surprises of -6.25% and 292.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ardelyx (ARDX) delivered earnings and revenue surprises of 500% and 59.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Aclaris (ACRS) delivered earnings and revenue surprises of 10.87% and 246.74%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
GWRS, EVBG, SPLK, RELL and HARP have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2023.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Harpoon Therapeutics, Inc. (HARP) could be a great choice. It is one of the several stocks...